Detalhe da pesquisa
1.
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study.
J Immunol
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758119
2.
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy.
Int J Urol
; 31(4): 404-408, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38154806
3.
HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.
Gastroenterology
; 162(3): 799-812, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687740
4.
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.
Cancer Immunol Immunother
; 72(6): 1903-1915, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729213
5.
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study.
Int J Urol
; 30(9): 788-796, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37528632
6.
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Cancer Immunol Immunother
; 71(3): 727-736, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379177
7.
The potential application of PD-1 blockade therapy for early-stage biliary tract cancer.
Int Immunol
; 32(4): 273-281, 2020 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31867666
8.
Independent validation of genetic risk model to progression after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer.
Int J Urol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687032
9.
Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer.
Int J Urol
; 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441353
10.
Importance of 3ß-hydroxysteroid dehydrogenases and their clinical use in prostate cancer.
Endocr Relat Cancer
; 31(7)2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38688318
11.
Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy to the prostate.
Asian J Endosc Surg
; 17(1): e13279, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212264
12.
Oxidative stress in peroxisomes induced by androgen receptor inhibition through peroxisome proliferator-activated receptor promotes enzalutamide resistance in prostate cancer.
Free Radic Biol Med
; 221: 81-88, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38762061
13.
The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: the KYUCOG-1401-A study.
Prostate Cancer Prostatic Dis
; 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368501
14.
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.
Sci Immunol
; 7(76): eabk0957, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206353
15.
Tim-3 mediates T cell trogocytosis to limit antitumor immunity.
J Clin Invest
; 132(9)2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316223
16.
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.
Cancer Cell
; 40(2): 201-218.e9, 2022 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090594
17.
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape.
Sci Immunol
; 6(65): eabc6424, 2021 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767457
18.
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity.
Clin Cancer Res
; 25(15): 4808-4819, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076547